Free shipping on all orders over $ 500

Gemcitabine Hydrochloride

Cat. No. M1716
Gemcitabine Hydrochloride Structure

Gemzar, LY-188011

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
50mg USD 42  USD42 In stock
100mg USD 53  USD53 In stock
200mg USD 69  USD69 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >99%
  • COA
  • MSDS
Biological Activity

Gemcitabine is an antimetabolites, which inhibits DNA synthesis with an IC50 of 0.06 µM. Gemcitabine is a nucleoside analogue that is incorporated into replicating DNA, resulting in partial chain termination and stalling of replication forks.

Product Citations
Cell Experiment
Cell lines BxPC-3, PANC-1 and PaCa-2 cell lines
Preparation method Cell Counts. The cells were plated in 6-well plates. Twenty-four hours later, the cells were treated with vehicle, gemcitabine, DMAPT, or the combination. After 72 h of treatment, trypan blue-excluded cell counts were performed in duplicate using a hemocytometer. Cell growth was expressed relative to vehicle-treated cells (100 %).
Concentrations 0, 0.005, 0.01, 0.02, 0.04 μM
Incubation time 72 h
Animal Experiment
Animal models MIA PaCa-2 Xenografts model in athymic nude mice
Formulation phosphate-buffered saline, PBS
Dosages a single dose of 50 or 100 mg/kg
Administration intraperitoneal injection
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 299.66
Formula C9H11F2N3O4.HCI
CAS Number 122111-03-9
Purity >99%
Solubility Water 50 mg/mL
DMSO 30 mg/mL
Storage 2-8°C, protect from light, dry, sealed

[1] Rich et al. Onco Targets Ther. Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer.

[2] Avan et al. Curr Pharm Des. Enhancement Of The Antiproliferative Activity Of Gemcitabine By Modulation Of C-Met Pathway In Pancreatic Cancer.

[3] Tajima et al. Exp Ther Med. Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancer.

[4] Kasuya et al. Exp Ther Med. Combination therapy of gemcitabine or oral S-1 with the anti-VEGF monoclonal antibody bevacizumab for pancreatic neuroendocrine carcinoma.

[5] Holcomb BK, et al. J Gastrointest Surg. Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.

Related Checkpoint Products

WAY-239320 is a Chk1 inhibitor

Prexasertib dimesylate

Prexasertib dimesylate (LY2606368 dimesylate) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM.


Prexasertib (LY2606368) is a selective, ATP-competitive second-generation checkpoint kinase 1 (CHK1) inhibitor with a Ki of 0.9 nM and an IC50 of <1 nM.

GDC-0575 dihydrochloride

GDC-0575 dihydrochloride (ARRY-575 dihydrochloride) is an orally bioavailable CHK1 inhibitor, with an IC50 of 1.2 nM, and has antitumor activity.


CCT244747 is a potent, orally bioavailable and highly selective CHK1 inhibitor, with an IC50 of 7.7 nM; CCT244747 also abrogates G2 checkpoint with an IC50 of 29 nM.

Abmole Inhibitor Catalog

Keywords: Gemcitabine Hydrochloride, Gemzar, LY-188011 supplier, Checkpoint, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.